MARCO PAGANI

Allopathic & Osteopathic Physicians|Internal Medicine|Nephrology BARRINGTON, IL NPI 1679728331

General Payments — all program years on this page

$1,873.10

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 35
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $616.32 across 15 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $616.3215

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $149.283
2019 $229.432
2022 $25.001
2023 $853.0714
2024 $616.3215

Records — PY2024 (15)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1087337431 Novartis Pharmaceuticals Corporation $29.42 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1091146294 ANI Pharmaceuticals, Inc. $25.74 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104285521 AstraZeneca Pharmaceuticals LP $14.67 09/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104578406 AstraZeneca Pharmaceuticals LP $18.76 08/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104597940 AstraZeneca Pharmaceuticals LP $15.54 11/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104723419 AstraZeneca Pharmaceuticals LP $18.95 04/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1104780468 AstraZeneca Pharmaceuticals LP $120.89 05/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118955534 Otsuka America Pharmaceutical, Inc. $25.69 01/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1118955536 Otsuka America Pharmaceutical, Inc. $22.30 12/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141515813 CALLIDITAS THERAPEUTICS US INC. $14.60 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141525010 CALLIDITAS THERAPEUTICS US INC. $23.37 10/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1141530057 CALLIDITAS THERAPEUTICS US INC. $24.73 12/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145116064 Mallinckrodt Hospital Products Inc. $27.99 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1149908049 Travere Therapeutics, Inc. $213.09 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150689073 Aurinia Pharma U.S., Inc. $20.58 02/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.